Medical Marketing and Media

Marketing Research Articles

Rate of provider-panel deals picks up steam

Marc Iskowitz February 01, 2012

The pace of deal-making in marketing research has quickened, as firms prepare for new regulation that could affect HCPs' survey participation.

InVentiv to buy SDI audits from IMS

Marc Iskowitz February 01, 2012

Privately held inVentiv Health is acquiring two of SDI Health's audit businesses worth under $15 million, firms said.

Vantage Point: Healthcare's new promotional target

Jerry Maynor January 01, 2012

Some analysts predict that over half of all calls by 2015 will be fielded by NPs, PAs and others

With KN buy, GfK aims for allied-health panel

Marc Iskowitz January 01, 2012

Research giant GfK said it is acquiring Knowledge Networks, a provider of digital research in the US. The acquisition, terms of which were not disclosed, extends over multiple business units, including healthcare.

UK open data stance: bold or brash?

Marc Iskowitz January 01, 2012

A UK proposal to make anonymous patient data available for pharma company research elicited cheers and jeers.

Vantage Point: What 2012 could bring

Richard Vanderveer December 01, 2011

Wrapping up what was remarkable about the past year, and pondering how the New Year will be the same and/or different.

Feds approve IMS's purchase of SDI Health

Marc Iskowitz December 01, 2011

IMS Health's acquisition of SDI Health was officially consummated, and its parent company is moving forward to divest two SDI product lines

Will social media replace surveys?

Marc Iskowitz December 01, 2011

Social media has emerged as a deep well of opinion but is an enigma for market researchers, says the co-founder of EmPower Research.

Vantage Point: Comparative Effectiveness Research

John Doyle November 01, 2011

Comparative Effectiveness Research (CER) is becomimg a key element in assessing the value of healthcare products.

IMS's Incivek reporting hitch spurs stock swing

Marc Iskowitz November 01, 2011

IMS Health continues to assess a data-supply glitch that led to an underreporting of prescriptions for Vertex Pharmaceuticals' hepatitis C drug Incivek.

« Previous

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.